Company Description
LifeVantage Corporation (Nasdaq: LFVN) is a health and wellness company that focuses on nutrigenomics, the study of how nutrition and naturally occurring compounds can influence genes and the health information coded within them. The company describes itself as the Activation company, with products designed to work with an individual’s biology and help the body make what it needs for health at the cellular level. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah.
LifeVantage operates in the pharmaceutical preparation manufacturing segment of the broader manufacturing sector, with a portfolio of dietary supplements, wellness systems, and personal care products. According to company disclosures, its line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the MindBody GLP-1 System, and the comprehensive gut activator P84. The company also offers activation-supporting nutrients such as Omega and D3+, the Rise AM & Reset PM System, AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs.
LifeVantage distributes its products through a direct selling model. The company states that its independent Consultants sell LifeVantage products to Customers and share a business opportunity with entrepreneurs who want to build their own businesses. This structure places emphasis on consultant education, events, and tools that support enrollment, retention, and advancement in the field.
Business focus and product ecosystem
LifeVantage emphasizes cellular activation as the organizing principle of its product strategy. The Protandim family and related activators are positioned to work with the body’s own processes. P84, which LifeVantage describes as a comprehensive gut activator, is part of this ecosystem and is associated with cellular pathways tied to gut regulation, repair, and restoration in in vitro research disclosed by the company. The MindBody GLP-1 System is presented as part of the company’s focus on natural GLP-1 activation and wellness related to metabolic pathways.
The company has highlighted combinations of products that form broader wellness systems. For example, LifeVantage has described the Healthy Edge wellness system as combining Protandim Nrf2 Synergizer with LoveBiome P84, bringing together established activation technology and newer gut-focused science. In a third-party in vitro study conducted in cells, the Healthy Edge combination was reported to activate a larger set of genes than either product alone, with a subset of genes associated with cellular learning, adaptability, and stress resilience, according to company communications. These findings are presented by LifeVantage as supporting the synergistic effects of using the combined products.
Nutrigenomics and scientific positioning
Across its public communications, LifeVantage consistently describes itself as a pioneer in nutrigenomics. The company’s narrative centers on the idea that nutrition and bioactive compounds can unlock gene-driven health potential. Its product descriptions reference scientifically validated activators and in vitro studies that examine gene expression, protein concentration, and cellular pathways. For example, LifeVantage has reported that P84 influenced multiple gut peptides and proteins in a controlled third-party study, and that changes exceeding typical biomarker thresholds were observed in this cell culture environment.
LifeVantage also discloses that its products and scientific claims are accompanied by standard regulatory disclaimers, noting that statements have not been evaluated by the U.S. Food and Drug Administration and that the products are not intended to diagnose, treat, cure, or prevent any disease. This positions the offerings within the dietary supplement and wellness framework rather than as approved pharmaceutical treatments.
Corporate structure and governance
LifeVantage is incorporated in Delaware and files regular reports with the U.S. Securities and Exchange Commission. The company holds an annual meeting of stockholders, elects directors to one-year terms, and submits executive compensation, auditor ratification, and equity incentive plan matters to advisory or binding stockholder votes, as reflected in its definitive proxy statements and related voting results. The company’s common stock is listed on Nasdaq under the symbol LFVN.
SEC filings indicate that LifeVantage maintains a board of directors and executive leadership team, and that stockholders vote on matters such as amendments to the 2017 Long-Term Incentive Plan and the selection of an independent registered public accounting firm. The company also reports on non-GAAP financial measures such as adjusted EBITDA and adjusted earnings per share, explaining how management uses these metrics to evaluate operating performance alongside GAAP results.
Events, consultants, and community
LifeVantage places notable emphasis on its consultant community and events. Company communications describe large-scale gatherings such as Momentum Academy and Global Kickoff, which are used to introduce new products, share training on wellness systems like Healthy Edge, and align Consultants around themes and business strategies. These events often coincide with product launches, updates to existing formulas, and the integration of newly acquired product lines.
The company has also discussed the integration of LoveBiome assets and consultant communities into LifeVantage. This integration brought P84 and other gut and microbiome-focused products into the LifeVantage portfolio and expanded the consultant base. Company statements describe this as aligning markets, products, culture, and leadership under a unified activation-focused vision.
Digital tools and technology
LifeVantage has highlighted its investment in digital capabilities to support both Consultants and Customers. The company has announced the Daily Activation mobile app, described as a centralized experience for tracking product usage, activation accelerators, and progress toward personal goals, and as a tool connected to the company’s Activate90 Challenge. LifeVantage has also appointed technology leadership to advance eCommerce, AI, CRM systems, mobile applications, and digital user experiences, with the stated aim of supporting consultant business growth and enhancing customer interactions.
Stock information and investor focus
As a publicly traded company, LifeVantage regularly issues press releases summarizing quarterly and annual financial results, dividend declarations, and participation in investor conferences. The company reports on revenue by region, gross profit, commissions and incentives, selling, general and administrative expenses, operating income, net income, and adjusted non-GAAP metrics. It also discloses share repurchase activity and dividend decisions, and provides guidance ranges for revenue, adjusted EBITDA, and adjusted earnings per share, while cautioning that forward-looking statements are subject to risks and uncertainties described in its SEC filings.
FAQs about LifeVantage Corporation
- What does LifeVantage Corporation do?
LifeVantage Corporation is a health and wellness company that focuses on nutrigenomics and cellular activation. It develops and sells dietary supplements, wellness systems, and personal care products, including the Protandim family, TrueScience Liquid Collagen, the MindBody GLP-1 System, P84, AXIO energy drink mixes, and TrueScience skin and hair care products. - How does LifeVantage distribute its products?
According to the company, LifeVantage products are sold through independent Consultants who sell to Customers and share a business opportunity with entrepreneurs interested in starting their own businesses. This direct selling model is central to how the company brings its products to market. - What is nutrigenomics in the context of LifeVantage?
LifeVantage describes nutrigenomics as the study of how nutrition and naturally occurring compounds can unlock genes and the health coded within them. The company positions its activator products as working with an individual’s unique biology to help the body produce what it needs for health. - What are some key LifeVantage products?
Company communications identify several key products: the Protandim family of activators, TrueScience Liquid Collagen, the MindBody GLP-1 System, the comprehensive gut activator P84, activation-supporting nutrients such as Omega and D3+, the Rise AM & Reset PM System, AXIO nootropic energy drink mixes, the TrueScience line of skin and hair care products, and Petandim for dogs. - What is the Healthy Edge wellness system?
Healthy Edge is described by LifeVantage as a wellness system that combines Protandim Nrf2 Synergizer with LoveBiome P84. In in vitro studies disclosed by the company, this combination was associated with activation of a large number of genes and a subset linked to cellular learning, adaptability, and stress resilience, suggesting synergistic effects when used together. - Where is LifeVantage headquartered and when was it founded?
LifeVantage states that it was founded in 2003 and is headquartered in Lehi, Utah. The company is incorporated in Delaware and its common stock trades on Nasdaq under the symbol LFVN. - How does LifeVantage describe the science behind P84?
In a third-party in vitro study reported by the company, P84 influenced multiple gut peptides and proteins in four gut cell types, with all measured peptides moving in what the company describes as the desired direction. Some peptides showed changes that exceeded typical biomarker thresholds considered biologically meaningful in such studies. - Does LifeVantage offer products for pets?
Yes. LifeVantage lists Petandim as a pet supplement formulated to combat oxidative stress in dogs, positioning it as part of the broader activation-focused product portfolio. - How does LifeVantage communicate with investors?
LifeVantage issues press releases, hosts conference calls, participates in investor conferences, and files periodic and current reports, proxy statements, and other documents with the SEC. These materials cover financial results, corporate governance matters, executive compensation, and other topics relevant to stockholders. - Are LifeVantage products approved to treat or cure diseases?
The company includes disclaimers stating that its product-related statements have not been evaluated by the Food and Drug Administration and that the products are not intended to diagnose, treat, cure, or prevent any disease. This places the offerings in the category of dietary supplements and wellness products rather than approved pharmaceuticals.
Stock Performance
Lifevantage (LFVN) stock last traded at $4.54, down 1.98% from the previous close. Over the past 12 months, the stock has lost 70.8%. At a market capitalization of $59.7M, LFVN is classified as a micro-cap stock with approximately 12.8M shares outstanding.
Latest News
Lifevantage has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include dividends, earnings, earnings date. View all LFVN news →
SEC Filings
Lifevantage has filed 5 recent SEC filings, including 3 Form 4, 1 Form EFFECT, 1 Form S-3. The most recent filing was submitted on March 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LFVN SEC filings →
Insider Radar
Insider buying activity at Lifevantage over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Lifevantage generated $228.5M in revenue over the trailing twelve months, retaining a 80.4% gross margin, operating income reached $12.2M (5.3% operating margin), and net income was $9.8M, reflecting a 4.3% net profit margin. Diluted earnings per share stood at $0.75. The company generated $11.9M in operating cash flow. With a current ratio of 1.87, the balance sheet reflects a strong liquidity position.
Upcoming Events
CEO retirement
Lifevantage has 1 upcoming scheduled event. The next event, "CEO retirement", is scheduled for April 1, 2026 (in 8 days). Investors can track these dates to stay informed about potential catalysts that may affect the LFVN stock price.
Short Interest History
Short interest in Lifevantage (LFVN) currently stands at 3.7 million shares, up 32.2% from the previous reporting period, representing 34.7% of the float. Over the past 12 months, short interest has increased by 141.2%. This high level of short interest suggests significant bearish sentiment among traders. With 13.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Lifevantage (LFVN) currently stands at 13.1 days, down 27.9% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 52.7% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 6.8 to 32.4 days.
LFVN Company Profile & Sector Positioning
Lifevantage (LFVN) operates in the Packaged Foods industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.
Investors comparing LFVN often look at related companies in the same sector, including Fitlife Brands Inc (FTLF), Bioharvest (BHST), Hain Celestial (HAIN), Beyond Meat (BYND), and BRC INC (BRCC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LFVN's relative position within its industry.